申请人:Jiangsu Provincial Institute Of Materia Medica Co.
公开号:EP2428506A1
公开(公告)日:2012-03-14
The present invention discloses a heterocyclic substituted acardite derivate and application thereof, namely compounds of the general formula (1) or the general formula (2) or pharmaceutically acceptable salts thereof, wherein A is monosubstituted or polysubstituted quinoline, isoquinoline, quinazoline, pyrrole or pyrimidine, and the substituent is halogen, C1-5alkyl, C1-5haloalkyl, C1-5alkoxy, C1-5haloalkoxy, C1-5alkylamino, C1-5haloalkylamino, amino or nitryl; R1 is C1-5alkyl; R2 is one or more selected from hydrogen, halogen, alkyl, alkoxy, haloalkyl or haloalkoxy; and R3 is one or more selected from hydrogen, halogen, alkyl, alkoxy, haloalkyl or haloalkoxy. The compound of the present invention and the pharmaceutically acceptable salt thereof can be used for treating tumor or leukemia.
本发明公开了一种杂环取代的乌头衍
生物及其应用,即通式(1)或通式(2)的化合物或其药学上可接受的盐、其中 A 是单取代或多取代的
喹啉、
异喹啉、
喹唑啉、
吡咯或
嘧啶,取代基是卤素、C1-5 烷基、C1-5 卤代烷基、C1-5 烷氧基、C1-5 卤代烷氧基、C1-5 烷基
氨基、C1-5 卤代烷基
氨基、
氨基或硝基;R1 是 C1-5 烷基;R2 是选自氢、卤素、烷基、烷氧基、卤代烷基或卤代烷氧基的一个或多个;以及 R3 是选自氢、卤素、烷基、烷氧基、卤代烷基或卤代烷氧基的一个或多个。本发明的化合物及其药学上可接受的盐可用于治疗肿瘤或白血病。